1.
Beal et al., (1994), Coenzym Q10 and Nicotinamide Block Striatal
Lesions Producted by the Mitochondrial Toxin Malonat, Annals
of Neurology, Vol. 36, No.6 pp. 882-888
2.
R. Luft, (1994), The development of mitochondrial medicine,
Proc.Natl. Acad.Sci., Vol. 91, pp. 8731-8738
3.
Brouillet, E. et al., (1994), Aminooxyacetic acid striatal
lesions attenuated by 1,3-butamediol and coenzyme Q10. Neurosci.
Lett. 177, 58-62
4.
Schulz, J.B. et al., (1995), Coenzyme Q10 and nicotinamide
and a free radical spin trap protect against MPTP neurotoxicity.
Exp.Neurol. 132, 279-283
5.
Koroshetz, W.J. et al., (1996) Assesment of energy metabolism
defects in Huntington´s disease and possible therapy with
CoenzymQ10 Ann. Neurol. In press
6.
Müller, U., Kriegelstein, J., (1994) Sauerstoffradikalfänger
als Neuroprotektiva, Dt.Apotheker Zeitung, Nr. 18, S.17 ff
7.
Busciglio, J., Yankner, B.A., (1995) Apoptosis and increased
generation of reactive oxygen species in Down´s syndrome neurons
in vitro, Nature, Vol. 378, pp 776-779
8.
Nishikawa, Y., et al., (1991) Evaluations of long-term therapeutic
effevtiveness of Coenzym Q10 on a case of Kearns-Sayre-syndrome,
in: Biomedical and clinical aspects of Coenzyme Q, ed. by
Folkers, K., Yamagani, T., Littarru, G.P., pp 375-382, Elsevier
Science Publishers.
9.
Schnell, O. et al., (1996) Zum Stellenwert neuer diagnostischer
Ansätze bei der kardialen autonomen Neuropathie des Typ-I-Diabetikes,
Diabetes und Stoffwechsel, 5, 127-134
10.
Linnane, A.W., (1996) The universality of bioenergetic disease,
an amelioration therapy: coenzym Q 10 and analogues.Abstracts:
9th International Symposium on Biomedical and Clinical Aspects
of Coenzym Q, Ancona, Italy, Institute of biochemistry, The
Univerity of Ancona.
11.
Koroshetz, W.J., et al., (1997) Energy metabolism defects
in Huntington´s disease and effects of Coenzym Q10, Ann. Neurol.
41:160-165
12.
Lodi, R., et al., (1994) The use of Phosphorus magnetic resonance
spectroscopy to study in vivo the effect of Coenzym Q10 treatment
in retinitis pigmentosa Molec.Aspects Med. Vol.15 (Supplement)
pp s221-s230
13.
Cahn, J., Borzeix, M.-G., (1984) The effect of Ubichinone
50 over the sub-acute phase of an experimental stroke in the
rat, in: Folkers, K., Yamamura, Y., (eds.), Biomedical and
clinical aspects of Coenzym Q, Volume 4, Elsevier Science
Publishers B.V.
14.
Hübner, C., et al., (1993) Decreased Plasma Ubiquinone-10
Concentration in Patients with Mevalonate Kinase Deficiency
Pediatr. Res. 34: 129-133
